Concepedia

Marie Maerevoet

MM

Statistics

Publications

26

Citations

2.1K

H-Index

21

Active since

1998

Affiliations

Institut Jules Bordet(Current)

Cliniques Universitaires Saint-Luc

Institut Gustave Roussy

Hôpital Saint-Louis

Inserm

Marie Maerevoet is an author at Institut Jules Bordet specializing in medicine, pathology, and oncology.

ORCID

Top concepts

Publications per year

1998–2022

26

Publications

26

Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial

Nagesh Kalakonda, Marie Maerevoet, Federica Cavallo et al. · The Lancet Haematology · 2020 · 324 citations · Full text

, , +4

Trastuzumab for Patients With Axillary-Node–Positive Breast Cancer: Results of the FNCLCC-PACS 04 Trial

M. Spielmann, Henri Roché, T. Delozier et al. · Journal of Clinical Oncology · 2009 · 298 citations

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

Nicolas Delanoy, Jean‐Marie Michot, Thibault Comont et al. · The Lancet Haematology · 2018 · 269 citations

, , +12

Multifactorial Approach to Predicting Resistance to Anthracyclines

Christine Desmedt, Angelo Di Leo, Evandro de Azambuja et al. · Journal of Clinical Oncology · 2011 · 187 citations

Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias

Peter Vandenberghe, Lucienne Michaux, Pierre Zachée et al. · Leukemia · 2004 · 181 citations

, , +8

1–5 of 26